EchoGo Pro vs Us2.v2
AI Verdict
Choose EchoGo Pro if…
Choose EchoGo Pro if your primary need is to automate and enhance the accuracy of stress echocardiography analysis specifically for the diagnosis of coronary artery disease. This cloud-based solution is ideal for facilities looking to generate near-instant, precise reports to streamline their stress echo workflow and improve CAD detection.
View EchoGo Pro →Choose Us2.v2 if…
Choose Us2.v2 if you require a comprehensive, fully automated AI solution for interpreting all types of echocardiograms, delivering complete structured reports with measurements and detection of a wide array of cardiac conditions. This tool is best suited for organizations aiming to significantly reduce overall echo reporting time and increase scan throughput across various cardiac diseases, with the flexibility of both cloud and on-premise deployment.
View Us2.v2 →For a physician evaluating AI tools for echocardiography, EchoGo Pro and Us2.v2 offer distinct advantages. EchoGo Pro, from Ultromics, specializes in automating stress echocardiography analysis, specifically aiming to improve the diagnosis of coronary artery disease (CAD). It provides near-instant, comprehensive reports and is a cloud-based solution designed for seamless integration into existing workflows, compatible with any PACS system. This tool is best suited for practices with a high volume of stress echo studies where the primary goal is efficient and accurate CAD diagnosis.
In contrast, Us2.v2 by Us2.ai offers a broader scope of automated echocardiogram interpretation. It delivers a complete structured echo report, including measurements, disease detection (such as cardiac amyloidosis, aortic stenosis, and heart failure), and clinical findings. A key practical difference is Us2.v2’s ability to automate 100% of the analysis, eliminating manual frame selection, and its flexibility with both cloud and on-premise deployment options. Physicians seeking a comprehensive AI solution for general echo interpretation, aiming to reduce overall reporting time and increase scan throughput across a wider range of cardiac conditions, would find Us2.v2 more aligned with their needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoGo Pro | Us2.v2 |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (SaaS) | Cloud, On-premise |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Us2.v2While both tools emphasize seamless integration and ease of use, Us2.v2 specifically highlights '100% AI automation, eliminating manual frame selection and annotation' and claims to reduce reporting time by up to 70%. This direct impact on workflow efficiency and reduced manual effort gives it an edge in practical usability.
Clinical Value
Us2.v2Both are FDA-cleared and provide automated echocardiogram analysis. However, Us2.v2 lists a broader range of automated disease detections, including cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, in addition to general findings. EchoGo Pro focuses primarily on stress echocardiography and coronary artery disease (CAD) diagnosis.
Pricing & Value
EchoGo ProBoth tools require direct contact for pricing, indicating a lack of public transparency. However, EchoGo Pro's description mentions the availability of reimbursement codes for related EchoGo products (e.g., CPT 0932T, NTAP XXE2X19). This suggests a clearer path for potential users to understand and secure financial reimbursement, adding tangible value beyond the product's cost.
Enterprise Readiness
Us2.v2Both tools are HIPAA compliant, have BAAs, and integrate with existing clinical systems (PACS, DICOM, HL7). However, Us2.v2 offers both cloud and on-premise deployment options, providing greater flexibility for enterprises with diverse IT infrastructure requirements or stringent data governance policies, whereas EchoGo Pro is exclusively cloud-based.
Innovation
Us2.v2Both leverage AI for automation, but Us2.v2 stands out with its claim of '100% AI automation, eliminating manual frame selection and annotation.' Furthermore, its 'guideline-adherent and explainable AI with transparent visual overlays and editable outputs' represents a significant innovation in fostering trust and clinical adoption by providing transparency into AI's decision-making process.
Support & Docs
TieNeither the provided structured facts nor web searches revealed specific details about publicly accessible support portals, detailed documentation libraries, or distinct customer support offerings for either product. Both companies appear to offer general contact methods for support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoGo Pro | Us2.v2 |
|---|---|---|
| Name | EchoGo Pro | Us2.v2 |
| Company | Ultromics | Eko.ai Pte. Ltd d/b/a Us2.ai |
| Description | EchoGo Pro is an FDA-cleared, AI-powered cloud solution by Ultromics that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports. | Us2.ai is an FDA-cleared, AI-powered tool that automates echocardiogram interpretation, delivering a complete structured echo report with measurements, disease detection, and clinical findings, making heart risk detection more accurate, consistent, and accessible worldwide. |
| Key Features | AI-powered automated echocardiogram analysis; Cloud-based service for accessibility and scalability; Automated identification of coronary artery disease (CAD); Provides near-instant, comprehensive reports; Improves diagnostic accuracy and reduces misdiagnosis; Vendor-neutral system, compatible with any PACS; Seamless integration with existing clinical workflows (DICOM, HL7); SaaS model requires no software installation or extensive training | 100% AI automation, eliminating manual frame selection and annotation; Delivers a complete structured echo report with measurements, disease detection, and clinical findings; Automated detection of cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease; Guideline-adherent and explainable AI with transparent visual overlays and editable outputs; Compatible with any ultrasound manufacturer (e.g., GE, Philips, Siemens, handheld POCUS); Integrates seamlessly with existing PACS, CVIS, or EMR systems (HL7 and DICOM SR supported); Offers both cloud and on-premise deployment options; Reduces reporting time by up to 70% and increases daily scan throughput |
Videos
Demos, reviews, and walkthroughs featuring EchoGo Pro and Us2.v2.